Longeveron Inc. (LGVN)
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
$30.30M
Dr. Joshua Michael Hare FACC, M.D.
18.00
Miami, FL
Feb 12, 2021
-0.24
$-8.86
3.86
4.18
-1,578.76%
-0.73
-0.00
0.95
25.35
4.18
-100.05%
-246.98%
Similar stocks (19)
Edgewise Therapeutics, Inc.
EWTX
Keros Therapeutics, Inc.
KROS
Erasca, Inc.
ERAS
Larimar Therapeutics, Inc.
LRMR
C4 Therapeutics, Inc.
CCCC
Generation Bio Co.
GBIO
Nutriband Inc.
NTRB
Kronos Bio, Inc.
KRON
Kezar Life Sciences, Inc.
KZR
RenovoRx, Inc.
RNXT
Bolt Biotherapeutics, Inc.
BOLT
Indaptus Therapeutics, Inc.
INDP
Kiora Pharmaceuticals, Inc.
KPRX
Forte Biosciences, Inc.
FBRX
ABVC BioPharma, Inc.
ABVC
Revelation Biosciences, Inc.
REVB
Pasithea Therapeutics Corp.
KTTA
Quoin Pharmaceuticals, Ltd.
QNRX
Better Therapeutics, Inc.
BTTX
Similar stocks (19)
Edgewise Therapeutics, Inc.
EWTX
Keros Therapeutics, Inc.
KROS
Erasca, Inc.
ERAS
Larimar Therapeutics, Inc.
LRMR
C4 Therapeutics, Inc.
CCCC
Generation Bio Co.
GBIO
Nutriband Inc.
NTRB
Kronos Bio, Inc.
KRON
Kezar Life Sciences, Inc.
KZR
RenovoRx, Inc.
RNXT
Bolt Biotherapeutics, Inc.
BOLT
Indaptus Therapeutics, Inc.
INDP
Kiora Pharmaceuticals, Inc.
KPRX
Forte Biosciences, Inc.
FBRX
ABVC BioPharma, Inc.
ABVC
Revelation Biosciences, Inc.
REVB
Pasithea Therapeutics Corp.
KTTA
Quoin Pharmaceuticals, Ltd.
QNRX
Better Therapeutics, Inc.
BTTX